Aspirin News and Research

RSS

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.

Revlimid clinical data in newly diagnosed multiple myeloma presented

Celgene Corporation announced today that data evaluating clinical results on Revlimid (lenalidomide) as a new therapeutic approach for patients with newly diagnosed multiple myeloma (MM) was presented at the American Society of Hematology 46th Annual Meeting in San Diego.

7 Dec 2004

New insight into anticoagulation therapies

Anticoagulation therapies, or treatments that reduce the amount of clotting factors in the blood, are quite common and used for a variety of reasons.

6 Dec 2004

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Having diabetes raises a woman's risk of having a heart attack to nearly 10 times

Having diabetes raises a woman's risk of having a heart attack to nearly 10 times that of other women, according to a study in the December issue of Diabetes Care. The study also describes why women with diabetes are at much higher risk than men with diabetes when it comes to having cardiac events.

23 Nov 2004

Not all congestion-producing chronic rhinosinusitis infections are the same

Rather, this problem that afflicts some 30 million Americans annually has four severity classifications that could help guide treatment today and help find better treatments in the future, says the lead author on the study published in the November issue of The Laryngoscope.

18 Nov 2004

Concord grapes increase good cholesterol

Drinking Concord grape juice significantly increased HDL--the good cholesterol--and significantly lowered two markers of inflammation in people with stable coronary artery disease, according to results of a study presented in the November issue of the journal Arteriosclerosis, Thrombosis and Vascular Biology.

16 Nov 2004

Startling new blood pressure findings - atherosclerosis slowed

A new study led by The Cleveland Clinic shows that giving blood pressure lowering medication to heart disease patients with a “normal” blood pressure dramatically reduces risk of adverse cardiac events and slows disease progression.

16 Nov 2004

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

A major Canadian-led global study has found that an inexpensive anti-blood-clotting drug significantly reduces death and repeat heart attacks without increasing the risk of stroke.

8 Nov 2004

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

This technology has demonstrated the ability to assess an individual's relative risk for heart attack by measuring the person's degree of aspirin resistance.

8 Nov 2004

Hong Kong launches flu vaccination programme

To prevent the spread of flu in the coming peak season, it is important that the public and private sectors work together to provide influenza vaccinations to members of the public.

8 Nov 2004

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.

4 Nov 2004

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

The Food and Drug Administration (FDA) has identified about 5 million doses of influenza vaccine from foreign manufacturers; HHS has been able to recoup an additional 300,000 doses of the injectable vaccine originally bought for federal employees and the military; and a major pneumonia vaccine manufacturer plans to triple its production.

29 Oct 2004

Selling paracetamol and other painkillers in smaller pack sizes has slashed rates of suicide

Selling paracetamol and other painkillers in smaller pack sizes has slashed rates of suicide and damage to the liver from paracetamol poisoning, concludes a study on bmj.com this week.

29 Oct 2004

Allopurinol, a common gout drug may also offer some protection against colorectal cancer

A commonly prescribed drug used to treat gout may also offer some protection against colorectal cancer, according to a new study from researchers at the University of Michigan and in Israel.

25 Oct 2004

Who should and who should not get a flu shot?

This year's supply of flu vaccine is limited. It is important that people at highest risk of serious illness or death from the flu get a flu shot. Complete this CDC form to see if you or your child should or should not get a flu shot.

25 Oct 2004

The aging American population means that more people are at risk for stroke

A leading stroke researcher says the aging of the American population means that more people are at risk for stroke, and unless new approaches are developed to reduce stroke incidence, it will surpass heart attacks and cancer as the major cause of long-term disability and premature death.

22 Oct 2004

New medication to prevent colon cancer

A Stony Brook University researcher is testing a new form of aspirin--one that is much more potent than its commercially available counterpart, but with almost none of the side effects--to determine whether it can be used to prevent colon cancer in patients who are prone to the disease.

21 Oct 2004

Study into ageing yields wealth of data

Any long-term study that follows people in their old age is bound to lose numbers because of deaths among its subjects, but the Australian Longitudinal Study of Ageing (ALSA) and many of its participants are still going strong.

19 Oct 2004

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Researchers at Brigham and Women’s Hospital (BWH) and colleagues have demonstrated for the first time in humans in a randomized clinical trial that low-dose aspirin - dosages equivalent to one baby aspirin (81 mg) - trigger the body to generate its own anti-inflammatory compounds that help fight unwanted inflammation.

13 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Aspirin News and Research

Revlimid clinical data in newly diagnosed multiple myeloma presented

New insight into anticoagulation therapies

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

Having diabetes raises a woman's risk of having a heart attack to nearly 10 times

Not all congestion-producing chronic rhinosinusitis infections are the same

Concord grapes increase good cholesterol

Startling new blood pressure findings - atherosclerosis slowed

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

Hong Kong launches flu vaccination programme

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

Selling paracetamol and other painkillers in smaller pack sizes has slashed rates of suicide

Allopurinol, a common gout drug may also offer some protection against colorectal cancer

Who should and who should not get a flu shot?

The aging American population means that more people are at risk for stroke

New medication to prevent colon cancer

Study into ageing yields wealth of data

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News